2003 Pharma Companies Pharmaceuticals Regulations 
Drug Discovery World
FEBRUARY 20, 2024
An obvious opportunity could be to demonstrate the interoperability of BlockSent with EDC systems that are commonly used in clinical trials by pharma companies and to combine BlockSent with a blockchain network offering a smart contract 15 capability. Ther Innov Regul Sci. BMJ 2003; 327: 484-487. 2020; 54: 1123-1133.
Drug Discovery World
FEBRUARY 20, 2024
An obvious opportunity could be to demonstrate the interoperability of BlockSent with EDC systems that are commonly used in clinical trials by pharma companies and to combine BlockSent with a blockchain network offering a smart contract 15 capability. Ther Innov Regul Sci. BMJ 2003; 327: 484-487. 2020; 54: 1123-1133.
Expert insights. Personalized for you.
130 
Let's personalize your content